BRD4 Inhibitor-38 (Compound 25) is an orally active BRD4 inhibitor, exhibiting IC50 values of 3.64 µM for BRD4 BD1 and 0.12 µM for BRD4 BD2. It also demonstrates anti-inflammatory properties, with an IC50 value of 1.98 µM for nitric oxide (NO) production.
Molekulargewicht:
338.357
Formel:
C19H18N2O4
Target-Kategorie:
Interleukin|||Epigenetic Reader Domain|||TNF
T204812
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
